Evidence map›Paper›PMID 37822829›Full record

ArticleBioinformation2023

Dangerous Risk Group-4 (RG-4) emergent viruses.

John T Sinnott, Charurut Somboonwit, Sally F Alrabaa, Paul Shapshak

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John T Sinnott1Department of Internal Medicine, Morsani College of Medicine, Tampa, Florida 33606, USA.
Charurut Somboonwit1Department of Internal Medicine, Morsani College of Medicine, Tampa, Florida 33606, USA.
Sally F Alrabaa1Department of Internal Medicine, Morsani College of Medicine, Tampa, Florida 33606, USA.
Paul Shapshak1Department of Internal Medicine, Morsani College of Medicine, Tampa, Florida 33606, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

World Health Organization (WHO) Risk Group-4 (RG-4) pathogens are among the most dangerous of the emergent and re-emergent viruses. International health agencies, working in concert, bridge the gaps in health care for populations at risk for RG-4 viral pathogen exposure. RG-4 virus research incorporates Biodefense Program and Biosafety Laboratory (BSL)-4 technologies. RG-4 viruses include Arena-

Indexed as

Arena-viridaebatbiodefenseBiosafety Laboratory (BSL)-4birdemergentFilo-viridaeFlavi-viridaeglobal warminghealthcare settingHerpes-viridaehumanmammalmosquitoNairo-viridaeNIAIDNIHParamyxo-viridaepigPox-viridaereptilereservoirsnaketickvectorWorld Health Organization (WHO) Risk Group 4 (RG-4) virus pathogens

Identifiers

PMID37822829
PMCPMC10563550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.